{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:58:15Z","timestamp":1760853495907},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ejphar.2010.06.022","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T08:10:00Z","timestamp":1277194200000},"page":"34-41","source":"Crossref","is-referenced-by-count":19,"title":["Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells"],"prefix":"10.1016","volume":"643","author":[{"given":"Anna","family":"Bielawska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"Pop\u0142awska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkadiusz","family":"Sura\u017cy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Czarnomysy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Bielawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.06.022_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-4781(01)00233-0","article-title":"Heterogeneous DNA binding modes of berenil","volume":"1519","author":"Barcelo","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2010.06.022_bib2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.bjc.6600854","article-title":"A phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)","volume":"88","author":"Beale","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2010.06.022_bib3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1124\/mol.65.6.1496","article-title":"DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs","volume":"65","author":"Beljanski","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.022_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.farmac.2003.12.002","article-title":"Synthesis and biological evaluation of new cyclic amidine analogs of chlorambucil","volume":"59","author":"Bielawska","year":"2004","journal-title":"Farmaco"},{"key":"10.1016\/j.ejphar.2010.06.022_bib5","first-page":"363","article-title":"Synthesis, DNA-binding affinity and cytotoxicity of the dinuclear platinum(II) complexes with berenil and amines ligands","volume":"65","author":"Bielawski","year":"2008","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"10.1016\/j.ejphar.2010.06.022_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.drup.2005.04.006","article-title":"Modifications of DNA by platinum complexes: relation to resistance of tumors to platinum antitumor drugs","volume":"8","author":"Brabec","year":"2005","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ejphar.2010.06.022_bib7","first-page":"936","article-title":"Evaluation of a tetrazolinium-based semiautomated colorimetric assay: assessment of chemosensitivity testing","volume":"47","author":"Carmichael","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2010.06.022_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1586\/14737140.6.7.973","article-title":"Satraplatin: an orally available platinum analog for the treatment of cancer","volume":"6","author":"Choy","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ejphar.2010.06.022_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tcb.2008.12.003","article-title":"Cell-cycle control in the face of damage\u2014a matter of life or death","volume":"19","author":"Clarke","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2010.06.022_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.iy.10.040192.001411","article-title":"Apoptosis and programmed cell death in immunity","volume":"10","author":"Cohen","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2010.06.022_bib11","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/jm00125a024","article-title":"Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin","volume":"32","author":"Debart","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2010.06.022_bib13","series-title":"Metal ions in Biological Systems","first-page":"251","article-title":"Polynuclear platinum drugs","author":"Farrell","year":"2004"},{"key":"10.1016\/j.ejphar.2010.06.022_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0079-6603(00)64006-0","article-title":"Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice","volume":"64","author":"Fortune","year":"2000","journal-title":"Prog. Nucleic Res. Mol. Biol."},{"key":"10.1016\/j.ejphar.2010.06.022_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0162-0134(95)00175-1","article-title":"Synthesis, characterization, and DNA modification induced by a novel Pt-berenil compound with cytotoxic activity","volume":"63","author":"Gonzalez","year":"1996","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejphar.2010.06.022_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cellsig.2009.10.009","article-title":"Transdominant regulation of integrin function: mechanisms of crosstalk","volume":"22","author":"Gonzalez","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2010.06.022_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1023720928680","article-title":"The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: biology and therapeutic relevance","volume":"22","author":"Gross","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejphar.2010.06.022_bib18","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/S0959-8049(02)00210-1","article-title":"Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression","volume":"38","author":"Ioachim","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2010.06.022_bib19","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M000777200","article-title":"Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes","volume":"275","author":"Kasparkova","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.06.022_bib20","doi-asserted-by":"crossref","first-page":"48076","DOI":"10.1074\/jbc.M208016200","article-title":"DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair","volume":"277","author":"Kasparkova","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.06.022_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbrc.2009.05.018","article-title":"C-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells","volume":"385","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2010.06.022_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2009.11.043","article-title":"The effect of telmisartan on collagen biosynthesis depends on the status of estrogen activation in breast cancer cells","volume":"628","author":"Kociecka","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.06.022_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00109-004-0555-y","article-title":"Nuclear factor-\u03baB: its role in health and disease","volume":"82","author":"Kumar","year":"2004","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejphar.2010.06.022_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-642-59766-4_4","article-title":"Interaction between cells and extracellular matrix: signaling by integrins and the elastin\u2013laminin receptor","volume":"25","author":"Labat-Robert","year":"2000","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"10.1016\/j.ejphar.2010.06.022_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2010.06.022_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/ar00084a001","article-title":"Newer approaches to the study of the mechanisms of action of antitumor antibiotics","volume":"15","author":"Lown","year":"1982","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejphar.2010.06.022_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ceb.2009.08.001","article-title":"Cytoskeletal control of growth and cell fate switching","volume":"21","author":"Mamoto","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejphar.2010.06.022_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jb\/mvm022","article-title":"Prolidase-independent mechanism of camptothecin-induced inhibition of collagen biosynthesis in cultured human skin fibroblasts","volume":"141","author":"Miltyk","year":"2007","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejphar.2010.06.022_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1039\/a705982e","article-title":"DNA minor-groove recognition by small molecules","volume":"18","author":"Neidle","year":"2001","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejphar.2010.06.022_bib30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3495(04)74178-8","article-title":"Characterization of a novel DNA minor-groove complex","volume":"86","author":"Nguyen","year":"2004","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2010.06.022_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0003-9861(90)90013-O","article-title":"Scorbutic and fasted guinea pig sera contain an insulin-like growth factor I reversible inhibitor of proteoglycan and collagen synthesis in chick embryo chondrocytes and adult human skin fibroblasts","volume":"276","author":"Oyamada","year":"1990","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2010.06.022_bib32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbrc.2010.03.029","article-title":"Role of the Akt\/mTOR survival pathway in cisplatin resistance in ovarian cancer cells","volume":"394","author":"Peng","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2010.06.022_bib33","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1210\/endo-128-4-1769","article-title":"Elevated activity of low molecular weight insulin-like growth factor-binding proteins in sera of vitamin C-deficient and fasted guinea pigs","volume":"128","author":"Peterkofsky","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2010.06.022_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0014-5793(94)00363-7","article-title":"Berenil acts as a poison of eukaryotic topoisomerase II","volume":"344","author":"Portugal","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2010.06.022_bib35","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1074\/jbc.275.15.10761","article-title":"Akt\/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein","author":"Pugazhenthi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.06.022_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1568011033482378","article-title":"Apoptosis induced by topoisomerase inhibitors","volume":"3","author":"Sordet","year":"2003","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.ejphar.2010.06.022_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.ejphar.2010.06.022_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2010.06.022_bib39","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1074\/jbc.R800011200","article-title":"Molecular machinery of mitochondrial fusion and fission","volume":"283","author":"Westermann","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.06.022_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1568011053765994","article-title":"Multi-nuclear platinum drugs: a new paradigm in chemotherapy","volume":"5","author":"Wheate","year":"2005","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.ejphar.2010.06.022_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/14728222.12.5.589","article-title":"Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer","volume":"12","author":"Yuen","year":"2008","journal-title":"Expert. Opin. Ther. Target"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910005923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910005923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T06:54:43Z","timestamp":1544424883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910005923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0014299910005923"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.06.022","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}